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Editorial
Making Sense of Non-Financial 
Competing Interests
The PLoS Medicine Editors
I
magine you’re a peer reviewer 
who’s received a request to referee 
a paper. The paper reports the 
results of a study using cell lines 
derived from an aborted fetus as a 
diagnostic tool in identifying certain 
viral infections. You are also a member 
of a religious organization morally 
opposed to fetal cell research. In your 
review, you raise questions about the 
study’s validity and methodology that 
might undermine the paper’s chance 
of publication.
Imagine you’re an editor and you 
receive a paper from the scientist 
who supervised your postdoctoral 
fellowship. It’s been a couple of 
years since you left his lab, but he 
has supported your career and you 
have warm feelings toward him; plus 
you still join your former lab mates 
occasionally at their monthly pub 
night. You select sympathetic reviewers 
and you fight hard for the paper at the 
editorial meeting.
These two scenarios reflect true 
ones; and each provides an example of 
how a personal interest might conflict 
with your responsibility to ensure the 
integrity of the publication process. 
Are such non-financial competing 
interests of less concern than 
commercial interests in the publication 
of research? Not if they disrupt honest 
reporting, fair review, and transparent 
publication.
Non-financial competing interests 
(sometimes called “private interests”) 
can be personal, political, academic, 
ideological, or religious. Like 
financial interests, they can influence 
professional judgment. Much as we’d 
like to believe that the reporting and 
evaluation of research are always 
objective, there is substantial evidence 
to the contrary [1]. Like all human 
activity, academic research and 
scientific publishing are inherently 
subjective, imperfect, and prone to 
bias, corruption, and self-interest. 
Indeed, because professional affinities 
and rivalries, nepotism, scientific or 
technological competition, religious 
beliefs, and political or ideological 
views are often the fuels for our 
passions and for our careers, private 
competing interests are perhaps even 
more potent than financial ones.
Furthermore, the very nature of 
academic and editorial work ensures 
that none of us are immune. Expertise 
in itself presents a kind of conflict of 
interest. Ask one of the top malarial 
researchers to declare her competing 
interests when reviewing a transmission 
modeling paper and she may say, “I am 
a direct competitor. Who could review 
this paper who was not?”
But how detrimental are private 
interests to the publication process? 
And what kind of guidance is out 




competing interests can 
influence professional 
judgment.
Taking a tour through the 
archives of COPE, the Committee 
on Publication Ethics (an advisory 
service for editors), reveals many 
cases of undeclared and problematic 
competing interests, and many of these 
go beyond the financial (http://www.
publicationethics.org.uk/). Harvey 
Marcovitch, chair of COPE, notes that 
half of the conflict of interest cases 
brought by editors and publishers 
to the last COPE Forum for advice 
involved non-financial interests 
(personal communication). But he also 
says that he isn’t yet convinced that 
bad publication behavior arising from 
non-financial competing interests is on 
the increase.
It would be fair to say, however, that 
awareness of the existence and impact 
of non-financial competing interests 
remains tiny relative to our awareness 
of financial bias. Studies continue to 
show that many if not most authors 
have some sort of financial stake in 
their publications, that these are 
often not declared, and that having a 
financial interest in research affects 
not only an author’s interpretation 
and conclusions, but the very design 
and execution of studies [2–4]. But no 
such evidence base exists for private 
interests. Because more is known about 
the impacts of financial interests, they 
have been easier for journals to define 
and to regulate. 
But it’s time to start taking non-
financial competing interests more 
seriously. As with all competing 
interests, what’s in dispute is not 
that they exist, but how to manage 
them. The responsibility of journals 
and the wider research communities 
is to safeguard the credibility of the 
scientific and editorial processes. Three 
things are needed to start making sense 
of non-financial competing interests.
First, Disclosure
Everyone has competing interests; 
financial or private, or both. The main 
problem with competing interests 
is nondisclosure [5]. As with all 
competing interests, it is not possible to 
reliably judge our own biases. Instead, 
declaring them allows others to make 
informed judgments about whether the 
competing interests are relevant or not.
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It’s necessary to establish a standard 
by which authors, reviewers, and 
editors are required to disclose whether 
they have non-financial interests that 
(1) might influence their reporting or 
review of the paper and/or (2) would 
negatively or positively be influenced 
by the publication of the paper. 
These interests would include unpaid 
board, governmental, or committee 
memberships; political or religious 
views; and personal relationships such 
as friendships or family relations, as 
well as mentoring and adversarial 
professional interactions. For example, 
authors should declare if they serve 
on the editorial board of the journal 
to which they are submitting or if they 
have acted as an expert witness in 
relevant legal proceedings. Reviewers 
should be expected to declare if they 
have held grants, co-authored papers, 
or worked in the same institution 
with the authors of the study they are 
reviewing.
Establishing such a standard is by 
no means easy. The BMJ abandoned 
attempts to require declarations of 
non-financial competing interests (it 
now simply encourages disclosure) 
because the definitions were disputed 
and the policy unworkable [6]. 
Neither JAMA, Nature Medicine, The
New England Journal of Medicine, nor 
Science require disclosure of private 
interests. A recent discussion on the 
listserv of the World Association of 
Medical Editors (WAME), whose 
editorial policy committee (of which 
JC is a member) is currently updating 
its conflict of interest policy, affirms 
how difficult it is to define and 
regulate private interests. In the 
end, because WAME members felt 
that non-financial conflicts were so 
nebulous and unquantifiable, WAME 
decided that the policy should remain 
focused on financial interests. 
Second, More Policy Development
Nevertheless, it is possible and, we 
believe, necessary to encourage 
openness in addressing some of the 
clearer sources of non-financial bias. 
Journals can’t police non-financial 
competing interests any more than 
they can police commercial interests. 
But they can develop clear and explicit 
policies that outline definitions of 
non-financial conflicts of interests 
and expectations for author, reviewer, 
and editorial behavior. PLoS has a 
comprehensive competing interest 
policy (http://journals.plos.org/
plosmedicine/competing.php)
that builds upon those of other 
organizations such as the Council 
of Science Editors (http://www.
councilscienceeditors.org/editorial_
policies/policies_endorsement.
cfm), the International Committee of 
Medical Journal Editors (http://www.
icmje.org/#conflicts), and WAME 
(http://www.wame.org/resources/
policies#fundres). Our policy states 
that no decision on papers submitted 
to PLoS journals will be made until 
the competing interests—financial, 
personal, and professional—of all 
authors are declared, and that we 
will publish all relevant positive and 
negative statements of competing 
interests. Reviewers are required 
to declare any interests that might 
interfere with their objective 
assessment of a manuscript, and 
these are considered by the editors 
in determining the suitability of the 
reviewer.
Editors are by no means above 
these standards of best practice. PLoS
Medicine, along with a very small 
number of other medical journals such 
as the BMJ [7],posts the competing 
interests of its editors in the interest of 
full disclosure (http://journals.plos.
org/plosmedicine/editors_interests.
php), and this seems a reasonable 
community standard for all journals. 
The PLoS policy also requires that 
individual editors recuse themselves 
from deliberations about papers 
authored by friends, colleagues, or 
adversaries [8].
Third, More Research
One impediment to good policy in 
this area is a lack of evidence. The 
development and implementation 
of explicit policies on non-financial 
competing interests will clearly benefit 
from being based upon strong evidence 
of the extent, nature, and impact of 
private interests. Although the evidence 
base on commercial influences on 
the scientific and editorial enterprises 
continues to mount, very little research 
has tackled non-financial competing 
interests.
There are a few notable exceptions. 
In a systematic review, Luborsky and 
colleagues found that a researcher’s 
allegiance to a given school of thought 
exerted a bias on the study design 
and outcomes of psychotherapy 
research comparable to that which 
has been documented for financial 
interests [9]. Examining the editorial 
process, Goldsmith and colleagues 
reviewed 228 consecutive manuscripts 
submitted to the Journal of Investigative 
Dermatology in 2003 [10] and found 
the odds of acceptance to be two 
times higher for manuscripts from 
which authors had excluded reviewers, 
compared to those whose authors had 
not done so. Quoted in Science [11], 
Goldsmith said “Excluding reviewers 
ends up being very, very important. 
People know their assassins.” Similarly, 
separate studies by Sara Schroter 
[12] and Liz Wager [13]support the 
idea that reviewers favorably biased 
toward the authors are more likely 
to recommend acceptance and less 
likely to advocate rejection than the 
(presumably) more objective editor-
selected reviewers.
These examples are intriguing, but 
many questions remain. Is it fair to 
assume editor-identified reviewers are 
more objective than author-suggested 
ones? Is it reasonable to prohibit a 
reviewer from refereeing the paper 
of his ex-wife, but allow him to review 
those of his ex-sister-in-law? What 
is the appropriate time period for 
excluding a reviewer on the basis of 
co-authorship or working in the same 
institution—one year, two years, five? 
Can a government employee report 
on the findings of her department’s 
research any more objectively than a 
pharmaceutical company employee 
reports his industry-funded work? 
Do religious views exert a more 
powerful effect than political ones? 
Who should judge editors’ competing 
interests? Is disclosure a panacea, or 
can it perversely provide a license to 
present more biased assertions [1]? 
And in specialized fields, isn’t almost 
everyone a friend, colleague, or 
competitor?
Despite the messy and imprecise 
nature of private interests, researchers 
and editors must persist in establishing 
a better understanding of their extent 
and impact. Any assumption that 
non-financial competing interests 
are less common or influential than 
financial incentives is probably 
misguided. It’s accepted that political 
interference in science is dangerous, 
that governments and funders do 
not make decisions on the basis of PLoS Medicine  |  www.plosmedicine.org 1301 September 2008  |  Volume 5  |  Issue 9  |  e199
science alone, and that intellectual 
and professional commitments often 
lead to strong personal views. When it 
comes to making sense of non-financial 
competing interests, why shouldn’t we 
be interested?  
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